FDA scientists find N-acetylcysteine has reasonable safety expectation as a supplement

FDA scientists find N-acetylcysteine has reasonable safety expectation as a supplement

Scientists from the US Food and Drug Administration conducted a systematic review of N-acetylcysteine (NAC) and concluded a reasonable expectation of safety for its use as a dietary supplement.

Source: Pooled analysis of studies, 41 high-quality human studies. It combines earlier studies, so its strength depends on the studies it pooled.

What was found

A systematic review by scientists at the US Food and Drug Administration (FDA) found a reasonable expectation of safety for N-acetylcysteine (NAC) when used as a dietary supplement.

The review identified one study that showed a statistically significant increase in nausea in patients with ulcerative colitis at a dose of 800 mg/day for 16 weeks. However, other high-quality studies found no corresponding increase in adverse effects with high doses, up to 9000 mg/day, and long durations, up to three years.

The scientists reported that NAC doses in clinical studies were comparable to recommended servings of available NAC-containing products, suggesting similar exposure levels and a similar safety profile.

How it was done

Scientists from the US Food and Drug Administration (FDA) conducted a systematic review to assess adverse effects linked to NAC, specifically for its use as a dietary supplement. They reviewed 149 studies and identified 41 high-quality studies for their analysis.

The review was part of the FDA's evaluation of whether to pursue rulemaking to remove NAC's exclusion from the statutory definition of a dietary supplement.

What it does not show

This systematic review is published online ahead of print, meaning it has not yet appeared in its final published form. The findings represent the views of the FDA scientists who authored the review, not an official ruling or decision by the FDA itself.

What happens next

The US Food and Drug Administration is evaluating whether to pursue rulemaking to remove N-acetylcysteine's exclusion from the statutory definition of a dietary supplement.

Where this fits

This review by FDA scientists suggests that N-acetylcysteine (NAC) has a reasonable expectation of safety when used as a dietary supplement. The doses studied in clinical trials were similar to those found in available NAC-containing products. Readers can compare the doses mentioned in this review with the serving sizes on supplement labels.

Read more: Supplement safe upper limits

Who was talking about it

  • CASRAI on the news (2026-11-16): CASRAI reported that the FDA has proposed a rule regarding NAC dietary supplements. See the post

The source

Safety Assessment for Ingested N-acetylcysteine Exposure: A Systematic Review. Toxicological Sciences, 2026-11-16.

This is news, reported from the source above. It is not medical advice and not a recommendation. Talk to your doctor or pharmacist before you change any medicine or supplement.

Free membership: Label updates, one full page of each kind a month and 25% off a first year.